【前列腺癌】「ArteraAI Prostate」獲FDA批准，首創AI預測非轉移性前列腺癌長期預後

 【前列腺癌】「ArteraAI Prostate」獲FDA De Novo批准，首創AI預測非轉移性前列腺癌長期預後

 文章出處  

Businesswire 

 

 原文標題  

Artera Receives U.S. FDA De Novo Marketing Authorization for AI-Digital Pathology Software Revolutionizing Prostate Cancer Care 

 

 文章序號  

8966 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2025 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.